Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neuroinflammation in Parkinson's disease: role in neurodegeneration and tissue repair
Sayinthen Vivekanantham, Savan Shah, Rizwan Dewji, et al.
International Journal of Neuroscience (2014) Vol. 125, Iss. 10, pp. 717-725
Closed Access | Times Cited: 153

Showing 1-25 of 153 citing articles:

Mitochondrial DNA in inflammation and immunity
Joel S. Riley, Stephen W. G. Tait
EMBO Reports (2020) Vol. 21, Iss. 4
Open Access | Times Cited: 605
Microbiome, probiotics and neurodegenerative diseases: deciphering the gut brain axis
Susan Westfall, Nikita Lomis, Imen Kahouli, et al.
Cellular and Molecular Life Sciences (2017) Vol. 74, Iss. 20, pp. 3769-3787
Open Access | Times Cited: 452
The Role of Microglia in Retinal Neurodegeneration: Alzheimer's Disease, Parkinson, and Glaucoma
Ana I. Ramı́rez, Rosa de Hoz, Elena Salobrar‐García, et al.
Frontiers in Aging Neuroscience (2017) Vol. 9
Open Access | Times Cited: 397
Cannabis sativa L. and Nonpsychoactive Cannabinoids: Their Chemistry and Role against Oxidative Stress, Inflammation, and Cancer
Federica Pellati, Vittoria Borgonetti, Virginia Brighenti, et al.
BioMed Research International (2018) Vol. 2018, pp. 1-15
Open Access | Times Cited: 313
The association between PM2.5 exposure and neurological disorders: A systematic review and meta-analysis
Pengfei Fu, Xinbiao Guo, Felix Man Ho Cheung, et al.
The Science of The Total Environment (2018) Vol. 655, pp. 1240-1248
Closed Access | Times Cited: 307
Glycogen synthase kinase-3 beta (GSK-3β) signaling: Implications for Parkinson's disease
Mojtaba Golpich, Elham Amini, Fatemeh Hemmati, et al.
Pharmacological Research (2015) Vol. 97, pp. 16-26
Closed Access | Times Cited: 236
Apelin-13 Suppresses Neuroinflammation Against Cognitive Deficit in a Streptozotocin-Induced Rat Model of Alzheimer’s Disease Through Activation of BDNF-TrkB Signaling Pathway
Huaiqing Luo, Yang Xiang, Xiangping Qu, et al.
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 148
Neuroprotective Activities of Curcumin in Parkinson’s Disease: A Review of the Literature
Eslam El Nebrisi
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 20, pp. 11248-11248
Open Access | Times Cited: 116
A Critical Role of Autophagy in Regulating Microglia Polarization in Neurodegeneration
Mengmeng Jin, Fen Wang, Di Qi, et al.
Frontiers in Aging Neuroscience (2018) Vol. 10
Open Access | Times Cited: 145
Pathological α-synuclein exacerbates the progression of Parkinson’s disease through microglial activation
Qiu-Shuang Zhang, Yang Heng, Yu‐He Yuan, et al.
Toxicology Letters (2016) Vol. 265, pp. 30-37
Closed Access | Times Cited: 135
Alpha-Synuclein Proteins Promote Pro-Inflammatory Cascades in Microglia: Stronger Effects of the A53T Mutant
Claire Hoenen, Audrey Gustin, Cindy Birck, et al.
PLoS ONE (2016) Vol. 11, Iss. 9, pp. e0162717-e0162717
Open Access | Times Cited: 132
The Anti-Inflammatory Role of Omega-3 Polyunsaturated Fatty Acids Metabolites in Pre-Clinical Models of Psychiatric, Neurodegenerative, and Neurological Disorders
Juliette Giacobbe, Bonnie Benoiton, Patricia A. Zunszain, et al.
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 113
An adverse outcome pathway for parkinsonian motor deficits associated with mitochondrial complex I inhibition
Andrea Terron, Anna Bal‐Price, Alicia Paini, et al.
Archives of Toxicology (2017) Vol. 92, Iss. 1, pp. 41-82
Open Access | Times Cited: 105
Resveratrol alleviates motor and cognitive deficits and neuropathology in the A53T α-synuclein mouse model of Parkinson's disease
Lifan Zhang, Xiaolin Yu, Mei Ji, et al.
Food & Function (2018) Vol. 9, Iss. 12, pp. 6414-6426
Closed Access | Times Cited: 103
Retinal ganglion cell death in glaucoma: Exploring the role of neuroinflammation
Rossella Russo, Giuseppe Pasquale Varano, Annagrazia Adornetto, et al.
European Journal of Pharmacology (2016) Vol. 787, pp. 134-142
Closed Access | Times Cited: 100
Purinergic mechanisms in neuroinflammation: An update from molecules to behavior
Edward Beamer, Flóra Gölöncsér, Gergely Horváth, et al.
Neuropharmacology (2015) Vol. 104, pp. 94-104
Open Access | Times Cited: 91
Understanding multifactorial architecture of Parkinson’s disease: pathophysiology to management
Ramandeep Kaur, Sidharth Mehan, Shamsher Singh
Neurological Sciences (2018) Vol. 40, Iss. 1, pp. 13-23
Open Access | Times Cited: 89
Gut microbiota differences between healthy older adults and individuals with Parkinson’s disease: A systematic review
Nathan D. Nuzum, Amy Loughman, Ewa A. Szymlek‐Gay, et al.
Neuroscience & Biobehavioral Reviews (2020) Vol. 112, pp. 227-241
Closed Access | Times Cited: 82
Nigral overexpression of α‐synuclein in a rat Parkinson’s disease model indicates alterations in the enteric nervous system and the gut microbiome
Sarah M. O’Donovan, Erin K. Crowley, Jillian R. Brown, et al.
Neurogastroenterology & Motility (2019) Vol. 32, Iss. 1
Closed Access | Times Cited: 77
Targeting the Mitochondrial Permeability Transition Pore to Prevent Age‐Associated Cell Damage and Neurodegeneration
Andrew Kent, Khairat Bahgat Youssef El Baradie, Mark W. Hamrick
Oxidative Medicine and Cellular Longevity (2021) Vol. 2021, Iss. 1
Open Access | Times Cited: 64
Gut–Brain Axis as a Pathological and Therapeutic Target for Neurodegenerative Disorders
Alma Rosa Lezama Toledo, Germán Rivera Monroy, Félipe Esparza Salazar, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1184-1184
Open Access | Times Cited: 61
Neuroprotective Effects of Resveratrol in In vivo and In vitro Experimental Models of Parkinson’s Disease: a Systematic Review
Michele Goulart dos Santos, Lúcia Emanueli Schimith, Corinne André‐Miral, et al.
Neurotoxicity Research (2022) Vol. 40, Iss. 1, pp. 319-345
Closed Access | Times Cited: 48
Cannabidiol: Bridge between Antioxidant Effect, Cellular Protection, and Cognitive and Physical Performance
George Jîtcă, Bianca Eugenia Ősz, Camil-Eugen Vari, et al.
Antioxidants (2023) Vol. 12, Iss. 2, pp. 485-485
Open Access | Times Cited: 24
The Potentiality of Natural Products and Herbal Medicine as Novel Medications for Parkinson’s Disease: A Promising Therapeutic Approach
Y. So, Jae-Ung Lee, Ga-Seung Yang, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1071-1071
Open Access | Times Cited: 10
Aberrations in circulating inflammatory cytokine levels in patients with Down syndrome: a meta-analysis
Yan Zhang, Meng Che, Jing Yuan, et al.
Oncotarget (2017) Vol. 8, Iss. 48, pp. 84489-84496
Open Access | Times Cited: 86
Page 1 - Next Page

Scroll to top